Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2488651000168114 | Tazac Pulvule (nizatidine 300 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2488661000168111 | Tazac Pulvule 300 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazac Pulvule 300 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Tazac Pulvule 300 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Tazac Pulvule 300 mg capsule | Is a | Tazac Pulvule | true | Inferred relationship | Some | ||
| Tazac Pulvule 300 mg capsule | Is a | nizatidine 300 mg capsule | true | Inferred relationship | Some | ||
| Tazac Pulvule 300 mg capsule | has manufactured dose form | hard capsule | false | Inferred relationship | Some | ||
| Tazac Pulvule 300 mg capsule | has intended active ingredient | nizatidine | true | Inferred relationship | Some | 283422998 | |
| Tazac Pulvule 300 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 283422999 | |
| Tazac Pulvule 300 mg capsule | has Australian BoSS | nizatidine | true | Inferred relationship | Some | 283422998 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tazac Pulvule 300 mg capsule, 30 | has TPUU | True | Tazac Pulvule 300 mg capsule | Inferred relationship | Some | 1 |
| Tazac Pulvule 300 mg capsule, 30, blister pack | has TPUU | True | Tazac Pulvule 300 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR